As a new grad nurse, I administered an intramuscular injection of fulvestrant, a hormonal therapy used to block estrogen receptors in breast cancer patients. The patient receives this injection monthly on both gluteal sites. During my first independent administration on the second gluteal site, I observed blood in the syringe upon needle removal. The patient suggested that the injection might have been mistakenly administered in the waist instead of the hip due to inaccurate landmarks. However, she reported feeling fine and left the facility.
Two days later, I followed up with the patient, and she reported experiencing nausea and diarrhea since the injection. She attributed these symptoms to the injection being administered in the waist instead of the hip. Even after two days, she continues to experience nausea. As a new grad nurse, I am concerned about the possibility of hitting a vessel or misplacement of the injection due to inaccurate landmarks. Could these symptoms be related to such issues?
As a new grad nurse, I administered an intramuscular injection of fulvestrant, a hormonal therapy used to block estrogen receptors in breast cancer patients. The patient receives this injection monthly on both gluteal sites. During my first independent administration on the second gluteal site, I observed blood in the syringe upon needle removal. The patient suggested that the injection might have been mistakenly administered in the waist instead of the hip due to inaccurate landmarks. However, she reported feeling fine and left the facility.
Two days later, I followed up with the patient, and she reported experiencing nausea and diarrhea since the injection. She attributed these symptoms to the injection being administered in the waist instead of the hip. Even after two days, she continues to experience nausea. As a new grad nurse, I am concerned about the possibility of hitting a vessel or misplacement of the injection due to inaccurate landmarks. Could these symptoms be related to such issues?